Plea To Extend Patent On Key Tuberculosis

New Delhi: The Indian Patent Office rejected US pharmaceutical giant Johnson & Johnson’s application to extend its monopoly on the key tuberculosis drug, bedaquiline, which is set to expire in July. On Thursday, the agency delivered…